ArticleCurrent microbiology2026
Secondary Metabolites from Diaporthe eres SK3, an Endophytic Fungus of Sellaginella kraussiana Sw. Collected from the Northeast Indian Hills, Exhibits Potential in Vitro Bioactivities.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endophytic fungi are vital producers of novel, pharmaceutically active metabolites and are reshaping the research landscape on natural products. Here, an endophytic fungus, Diaporthe eres SK3, was isolated from Selaginella kraussiana Sw., collected from the forests of Arunachal Pradesh, and produces antimicrobial and antioxidative metabolites. Chemo-profiling of the SK3 metabolites using column chromatographic and spectroscopic techniques reveals the presence of isovaleric acid, benzyl alcohol, dibutyl phthalate, phenethylamine, and 2,4-di-tert-butylphenol. Killing kinetics assays confirmed the microbicidal activity of this metabolite against a panel of microbes, including MRSA, Candida albicans, and Candida tropicalis, with a Minimum Microbicidal Concentration (MMC) of 12.5-350 µg mL
Indexed as
Identifiers
42171756What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.